Nitric oxide levels in patients with diabetes mellitus: A systematic review and meta-analysis

American Diabetes Association, 2015, Classification and diagnosis of diabetes, Diabetes Care, 38

American Diabetes Assocation, 2012, Diagnosis and classification of diabetes mellitus, Diabetes Care, 35, S64, 10.2337/dc12-s064

International Diabetes Federation. Epidemiology [Available from:www.idf.org].

Pfeilschifter, 1995, Does nitric oxide, an inflammatory mediator of glomerular mesangial cells, have a role in diabetic nephropathy?, Kidney Int., 51, S50

Avogaro, 2011, Endothelial dysfunction in diabetes: the role of reparatory mechanisms, Diabetes Care, 34, S285, 10.2337/dc11-s239

Schmidt, 1994, NO at work, Cell, 78, 919, 10.1016/0092-8674(94)90267-4

Dellamea, 2014, Nitric oxide system and diabetic nephropathy, Diabetol. Metab. Syndr., 6, 17, 10.1186/1758-5996-6-17

Napoli, 2009, Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases, Arch. Pharmacol. Res., 32, 1103, 10.1007/s12272-009-1801-1

Bredt, 1994, Nitric oxide: a physiologic messenger molecule, Ann. Rev. Biochem., 63, 175, 10.1146/annurev.bi.63.070194.001135

Caimi, 2012, Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome, Diabetes Metab. Syndr., 6, 132, 10.1016/j.dsx.2012.09.012

Zou, 2004, Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus, Endothelium, 11, 89, 10.1080/10623320490482619

Pacher, 2007, Nitric oxide and peroxynitrite in health and disease, Physiol. Rev., 87, 315, 10.1152/physrev.00029.2006

Brownlee, 2005, The pathobiology of diabetic complications: a unifying mechanism, Diabetes, 54, 1615, 10.2337/diabetes.54.6.1615

Pitocco, 2010, Oxidative stress, nitric oxide, and diabetes, Rev. Diabet. Stud., 7, 15, 10.1900/RDS.2010.7.15

Beckman, 1993, Pathological implications of nitric oxide, superoxide and peroxynitrite formation, Biochem. Soc. Trans., 21, 330, 10.1042/bst0210330

Honing, 1998, Nitric oxide availability in diabetes mellitus, Diabetes Metab. Rev., 14, 241, 10.1002/(SICI)1099-0895(1998090)14:3<241::AID-DMR216>3.0.CO;2-R

Förstermann, 2010, Nitric oxide and oxidative stress in vascular disease, Pflugers Arch., 459, 923, 10.1007/s00424-010-0808-2

Adela, 2015, Hyperglycaemia enhances nitric oxide production in diabetes: a study from South Indian patients, PLoS One, 10, e0125270, 10.1371/journal.pone.0125270

Aydin, 2001, Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control, Clin. Biochem., 34, 65, 10.1016/S0009-9120(00)00199-5

Hoeldtke, 2003, Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes, J. Clin. Endocrinol. Metab., 88, 1624, 10.1210/jc.2002-021525

Mylona-Karayanni, 2006, Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link, Pediatr. Diabetes, 7, 51, 10.1111/j.1399-543X.2006.00147.x

Pitocco, 2009, Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus, Diabetes Res. Clin. Pract., 86, 173, 10.1016/j.diabres.2009.09.019

Daimon, 2000, Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes, Diabetes Care, 23, 559, 10.2337/diacare.23.4.559

Krause, 2012, Differential nitric oxide levels in the blood and skeletal muscle of type 2 diabetic subjects may be consequence of adiposity: a preliminary study, Metab. Clin. Exp., 61, 1528, 10.1016/j.metabol.2012.05.003

Shiekh, 2011, Reduced nitrate level in individuals with hypertension and diabetes, J. Cardiovasc Dis. Res., 2, 172, 10.4103/0975-3583.85264

Bender, 2007, Diet-induced obesity and diabetes reduce coronary responses to nitric oxide due to reduced bioavailability in isolated mouse hearts, Diabetes Obes. Metab., 9, 688, 10.1111/j.1463-1326.2006.00650.x

Kim, 2008, Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance, Arterioscler. Thromb. Vasc. Biol., 28, 1982, 10.1161/ATVBAHA.108.169722

Tatsch, 2012, Association between DNA strand breakage and oxidative, inflammatory and endothelial biomarkers in type 2 diabetes, Mutat. Res., 732, 16, 10.1016/j.mrfmmm.2012.01.004

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, J. Clin. Epidemiol., 62, 1006, 10.1016/j.jclinepi.2009.06.005

Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008

de Souza, 2013, Associations between UCP1 -3826A/G, UCP2 -866G/A, Ala55Val and Ins/Del, and UCP3 -55C/T polymorphisms and susceptibility to type 2 diabetes mellitus: case-control study and meta-analysis, PLoS One, 8, e54259, 10.1371/journal.pone.0054259

Brondani, 2014, Meta-analysis reveals the association of common variants in the uncoupling protein (UCP) 1-3 genes with body mass index variability, PLoS One, 9, e96411, 10.1371/journal.pone.0096411

Sortica, 2015, Association between the ENPP1 K121Q polymorphism and risk of diabetic kidney disease: a systematic review and meta-analysis, PLoS One, 10, e0118416, 10.1371/journal.pone.0118416

Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur. J. Epidemiol., 25, 603, 10.1007/s10654-010-9491-z

Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat. Med., 21, 1539, 10.1002/sim.1186

Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557

Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629

Milsom, 2002, Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus, Diabetologia, 45, 1515, 10.1007/s00125-002-0956-9

Savino, 2006, Serum and urinary nitrites and nitrates and Doppler sonography in children with diabetes, Diabetes Care, 29, 2676, 10.2337/dc06-0346

Ferlito, 1998, Nitrite plasma levels in type 1 and 2 diabetics with and without complications, Panminerva Med., 40, 304

Chiarelli, 2000, Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration, Diabetes, 49, 1258, 10.2337/diabetes.49.7.1258

Hoeldtke, 2002, Nitrosative stress, uric Acid, and peripheral nerve function in early type 1 diabetes, Diabetes, 51, 2817, 10.2337/diabetes.51.9.2817

Catalano, 1997, Basal nitric oxide production is not reduced in patients with noninsulin-dependent diabetes mellitus, Vasc. Med., 2, 302, 10.1177/1358863X9700200405

Maejima, 2001, Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications, J. Diabetes Complicat., 15, 135, 10.1016/S1056-8727(01)00144-1

Doganay, 2002, Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus, Eye (Lond), 16, 163, 10.1038/sj/eye/6700095

Izumi, 2006, Relation between plasma nitric oxide levels and diabetic retinopathy, Jpn. J. Ophthalmol., 50, 465, 10.1007/s10384-006-0344-y

Guerra, 2008, Correlación entre la concentración de nitritos y albuminuria en pacientescon diabetes tipo 2 normotensos e hipertensos, Med. Int. Mex., 24, 329

Nunes, 2009, Semicarbazide-sensitive amine oxidase activity and total nitrite and nitrate concentrations in serum: novel biochemical markers for type 2 diabetes?, Acta Diabetol., 46, 135, 10.1007/s00592-008-0070-7

Ghosh, 2011, Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim, Int. J. Appl. Basic Med. Res., 1, 31, 10.4103/2229-516X.81977

Chien, 2005, Increased plasma concentration of nitric oxide in type 2 diabetes but not in nondiabetic individuals with insulin resistance, Diabetes Metab., 31, 63, 10.1016/S1262-3636(07)70168-4

Ouvina, 2001, Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients, Thromb. Res., 102, 107, 10.1016/S0049-3848(01)00237-7

Vanizor, 2001, Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications, Diabetes Res. Clin. Pract., 54, 33, 10.1016/S0168-8227(01)00281-9

Abou-Seif, 2004, Evaluation of some biochemical changes in diabetic patients, Clin. Chim. Acta, 346, 161, 10.1016/j.cccn.2004.03.030

Pereira, 2006, Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type 2 diabetes mellitus, Mediat. Inflamm., 2006, 39062

Apakkan Aksun, 2003, Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration, J. Diabetes Complicat., 17, 343, 10.1016/S1056-8727(02)00196-4

Zahedi Asl, 2008, Serum nitric oxide metabolites in subjects with metabolic syndrome, Clin. Biochem., 41, 1342, 10.1016/j.clinbiochem.2008.08.076

Ghasemi, 2010, Reference values for serum nitric oxide metabolites in an adult population, Clin. Biochem., 43, 89, 10.1016/j.clinbiochem.2009.09.011

Lau, 2006, The case of the misleading funnel plot, BMJ, 333, 597, 10.1136/bmj.333.7568.597

Yang, 2010, Hyperglycemia induces inducible nitric oxide synthase gene expression and consequent nitrosative stress via c-Jun N-terminal kinase activation, Am. J. Obstet. Gynecol., 203, 185, 10.1016/j.ajog.2010.05.003

Zhang, 2014, PERK pathway are involved in NO-induced apoptosis in endothelial cells cocultured with RPE under high glucose conditions, Nitric oxide, 40, 10, 10.1016/j.niox.2014.05.001

Cai, 2005, Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells, Cardiovasc Res., 65, 823, 10.1016/j.cardiores.2004.10.040

Shahid, 2009, Correlation between glycosylated hemoglobin (HbA1c) and serum nitrite oxide (NO), Aust. J. Basic Appl. Sci., 3, 1323

Ishii, 2001, Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus, J. Am. Soc. Nephrol., 12, 1630, 10.1681/ASN.V1281630

Cosentino, 1997, High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells, Circulation, 96, 25, 10.1161/01.CIR.96.1.25

Duplain, 2001, Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase, Circulation, 104, 342, 10.1161/01.CIR.104.3.342

Shankar, 2000, Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance, Diabetes, 49, 684, 10.2337/diabetes.49.5.684

Kapur, 1997, Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action, Diabetes, 46, 1691, 10.2337/diab.46.11.1691

Perreault, 2001, Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle, Nat. Med., 7, 1138, 10.1038/nm1001-1138

Tsuchiya, 2007, Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice, Endocrinol, 148, 4548, 10.1210/en.2006-1371

Noronha, 2005, Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity, Diabetes, 54, 1082, 10.2337/diabetes.54.4.1082

Cha, 2010, Lack of inducible nitric oxide synthase does not prevent aging-associated insulin resistance, Exp. Geront, 45, 711, 10.1016/j.exger.2010.05.004

Kurohane Kaneko, 2013, Dual role of nitric oxide in pancreatic beta-cells, J. Pharmacol. Sci., 123, 295, 10.1254/jphs.13R10CP

Smukler, 2002, Exogenous nitric oxide and endogenous glucose-stimulated beta-cell nitric oxide augment insulin release, Diabetes, 51, 3450, 10.2337/diabetes.51.12.3450

Eizirik, 1996, The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells, Diabetologia, 39, 875, 10.1007/BF00403906

Wu, 1995, Nitric oxide synthesis and the effect of aminoguanidine and NG-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat, Diabetes, 44, 360, 10.2337/diab.44.3.360

Cnop, 2005, Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities, Diabetes, 54, S97, 10.2337/diabetes.54.suppl_2.S97

Flodstrom, 1999, Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes, Diabetes, 48, 706, 10.2337/diabetes.48.4.706

Takamura, 1998, Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis, J. Biol. Chem., 273, 2493, 10.1074/jbc.273.5.2493

Mata-Greenwood, 2008, Racial differences in nitric oxide-dependent vasorelaxation, Reprod. Sci., 15, 9, 10.1177/1933719107312160

Cantu-Medellin, 2013, Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: insights regarding where, when and how, Nitric oxide, 34, 19, 10.1016/j.niox.2013.02.081

Battelli, 2014, Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress, Atherosclerosis, 237, 562, 10.1016/j.atherosclerosis.2014.10.006